Dotimas, Kent John S.

HRN: 12-94-87  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2022
CEFUROXIME 750MG (VIAL)
09/13/2022
09/19/2022
IV
700mg
Q8hours
UTI
Waiting Final Action 
09/14/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/14/2022
09/21/2022
IV
350 Mg
Q 8 HRS
Acute Suppurative Appendicitis
Waiting Final Action 
09/14/2022
CEFTRIAXONE 1G (VIAL)
09/14/2022
09/20/2022
IVT
2g
Od
Uti; T/c Acute AP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: